CHMP Recommends EU Approval of Updated Libtayo Dosing Regimen

The positive opinion supports dosing every six weeks after the first 12 weeks of treatment, instead of every three weeks. It also recommends reducing infusion time for the 350 mg dose to 15–30 minutes after a well-tolerated first dose over 30 minutes.